Metric Finance
LearnFAQ
LearnFAQ

Learn / NVO

NYSE: NVO

Novo Nordisk A S (NVO) stock, explained like you're 5

Novo Nordisk A S trades on the New York Stock Exchange under the ticker NVO. It is a large cap company in the pharmaceutical preparations industry, part of the healthcare sector, with a market value of about 171.1 billion dollars.

Ticker
NVO
Exchange
New York Stock Exchange
Sector
Healthcare
Industry
Pharmaceutical Preparations
Size
Large cap, about 171.1 billion dollars

Is Novo Nordisk A S a small, medium or large cap company?

Yes. Novo Nordisk A S is a large cap stock. Its market cap, which is the total value of all its shares, is about 171.1 billion dollars.

Here is how you can tell. Multiply the share price by the number of shares to get the market cap, then compare it to the usual sizes. Micro cap is under 300 million dollars, small cap is 300 million to 2 billion, mid cap is 2 to 10 billion, large cap is 10 billion and up, and mega cap is over 200 billion. Market caps move every day with the share price, so treat the number as a recent snapshot.

How Novo Nordisk A S makes money

  • Selling medicines, medical devices or healthcare services.
  • Insurance premiums or hospital and clinic fees.
  • Research and licensing deals.

What moves NVO stock

  • Results from clinical trials and approvals from regulators.
  • Drug prices, insurance rules and government policy.
  • Patents running out and new competing treatments.

In the news lately

  • Novo Nordisk (NVO) Could Be 63% Undervalued Following Its Share Buyback (Yahoo Finance)
  • NVO Stock Slumps After Late Stage Trial Fails Primary Goal Retail Says ‘Current Revenue Drivers’ Still Intact (Stocktwits)
  • Novo Nordisk (NVO) Stock May Be Undervalued As Buybacks Continue (Simply Wall Street)
  • Novo Nordisk A/S Stock (NVO) Moved Up by 3.38% on Oct 15: What Investors Need To Know (TradingKey)
  • NVO Nov 2026 44.000 call (NVO261113C00044000) Stock Historical Prices & Data (Yahoo! Finance Canada)

Follow NVO in your daily brief

Each trading day at 5 PM ET we post what happened to Novo Nordisk A S and why it matters, in simple words. Free.

Start my free brief

Key terms to know before you follow NVO

  • Market cap
  • P/E ratio
  • EPS (earnings per share)
  • Earnings report
  • Volatility

Questions about Novo Nordisk A S stock

What does Novo Nordisk A S do?

Novo Nordisk A S trades on the New York Stock Exchange under the ticker NVO. It is a large cap company in the pharmaceutical preparations industry, part of the healthcare sector, with a market value of about 171.1 billion dollars.

What is the ticker symbol for Novo Nordisk A S?

Novo Nordisk A S trades under the ticker NVO on the New York Stock Exchange.

What is Novo Nordisk A S's market cap?

Novo Nordisk A S is a large cap stock with a market cap of about 171.1 billion dollars.

How does Novo Nordisk A S make money?

Selling medicines, medical devices or healthcare services. Insurance premiums or hospital and clinic fees. Research and licensing deals.

What moves NVO stock?

Results from clinical trials and approvals from regulators. Drug prices, insurance rules and government policy. Patents running out and new competing treatments.

How can I follow NVO stock every day?

Add NVO to your watchlist on Metric Finance. We post a free brief every trading day at 5 PM ET that explains what happened to the stocks you follow, in simple words.

Follow NVO daily

A free brief on Novo Nordisk A S and your other stocks, every trading day at 5 PM ET.

Start my free brief

Similar stocks

  • NVS · Novartis AG
  • AZN · Astrazeneca PLC
  • VRTX · Vertex Pharmaceuticals Inc / Ma
  • SNY · Sanofi

Similar stocks

  • NVSNovartis AG
  • AZNAstrazeneca PLC
  • VRTXVertex Pharmaceuticals Inc / Ma
  • SNYSanofi

Compare NVO: NVO vs NVS, NVO vs AZN, NVO vs VRTX

Educational information, not financial advice. This guide explains the business in general terms and does not include live prices.

Metric Finance

Stocks explained like you're 5.

Product

  • Learn
  • FAQ
  • Your account

Legal

  • Privacy
  • Terms

Support

  • Contact
  • Unsubscribe

© 2026 Metric Finance

Built by Yashna & Vansh · Not investment advice · Market data may be delayed